Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P. Mismetti
Ds2 - Effectiveness and Safety of Standard and Reduced Doses of Dabigatran Versus Rivaroxaban in Non-Valvular Atrial Fibrillation: A Cohort Study in the SNDS French Nationwide Claims Database
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Comparative Effectiveness and Safety of Warfarin and Dabigatran in Patients With Non-Valvular Atrial Fibrillation in Japan: A Claims Database Analysis
Journal of Cardiology
Cardiovascular Medicine
Cardiology
Effectiveness and Safety of 110 or 150 Mg Dabigatran Versus Vitamin K Antagonists in Non-Valvular Atrial Fibrillation.
British Journal of Clinical Pharmacology
Pharmacology
Cost-Effectiveness of Rivaroxaban for the Prevention of Stroke in Patients With Non-Valvular Atrial Fibrillation – A Multinational Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Study Design and Baseline Characteristics of the EXPAND Study: Evaluation of Effectiveness and Safety of Xa Inhibitor, Rivaroxaban for the Prevention of Stroke and Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-Valvular Atrial Fibrillation
Tohoku Journal of Experimental Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Comparative Pharmacoeconomic Analysis of Rivaroxaban and Warfarin Usage in Patients With Non-Valvular Atrial Fibrillation
Jounal of arrhythmology
Major Bleeding With Dabigatran and Rivaroxaban in Patients With Atrial Fibrillation
Clinical and Applied Thrombosis/Hemostasis
Medicine
Hematology
Prm20 - Clinical Effectiveness and Safety of Standard-Dose and Low-Dose Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation: A Nationwide Population-Based Cohort Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation: Propensity Weighted Nationwide Cohort Study
British Medical Journal
Medicine
